Palestinian Health Ministry announces critical disruption in cancer care due to ongoing conflict and resource shortages.
The Palestinian Ministry of Health announced on Thursday the suspension of intravenous chemotherapy services and medical follow-up for cancer patients in the Gaza Strip.
This decision has been attributed to the evacuation of the European Hospital and the Gaza Cancer Center, which, according to the ministry's statement on
Facebook, has exacerbated the already dire situation for these patients.
Currently, there are approximately 11,000 cancer patients in Gaza without access to adequate treatment and healthcare services.
Of these, 5,000 patients are in urgent need of referrals for treatment abroad, either for diagnosis or for chemotherapy and radiotherapy procedures.
The ministry emphasized that the lack of early diagnostic equipment and follow-up care has further deteriorated the health conditions of these patients.
Additionally, it reported that 64% of cancer medications are currently out of stock, limiting treatment options significantly.
The Health Ministry of Gaza highlighted that cancer patients are facing catastrophic health, social, psychological, and economic conditions.
It has called on various organizations to exert pressure on the occupying forces to allow the patients to travel abroad for necessary treatment and to facilitate the entry of essential medications into Gaza.